ICU, Medegen Settle IV Connection Patent Spat

Law360, New York (August 4, 2009, 5:38 PM EDT) -- ICU Medical Inc. and rival Medegen MMS Inc. have buried the hatchet in their battle over Medegen's patent for a needle-free intravenous connection.

The companies filed a stipulated dismissal Tuesday in the U.S. District Court for the Central District of California, dismissing the original complaint and counterclaims without prejudice and agreeing to bear their own costs.

“ICU Medical and Medegen are pleased to shift their focus from the litigation to their business relationship,” the companies said in a Tuesday statement.

Further information on the settlement was...
To view the full article, register now.